• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的局部和全身骨骼影响

[Local and systemic bone effects of rheumatoid arthritis].

作者信息

Rauner M, Hofbauer L C, Aringer M

机构信息

Bereich Endokrinologie, Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland.

出版信息

Z Rheumatol. 2012 Dec;71(10):869-73. doi: 10.1007/s00393-011-0927-y.

DOI:10.1007/s00393-011-0927-y
PMID:22806699
Abstract

Rheumatoid arthritis (RA) is a bone-destructive disease that is a serious risk factor for the development of osteoporosis, which is defined by a loss in bone quality and an increased fracture risk. The proinflammatory cytokines tumor necrosis factor-α (TNFα), interleukin-6 (IL-6) and IL-17, in particular, contribute to local and systemic bone loss in RA. While effectively reducing inflammation, glucocorticoids add to the fracture risk. Therefore, an adequate supply of calcium and vitamin D is essential. For many patients with RA, bone density measurements are recommended.

摘要

类风湿性关节炎(RA)是一种具有骨质破坏作用的疾病,是骨质疏松症发生的严重风险因素,骨质疏松症的定义为骨质质量下降和骨折风险增加。特别是促炎细胞因子肿瘤坏死因子-α(TNFα)、白细胞介素-6(IL-6)和IL-17,在类风湿性关节炎中会导致局部和全身性骨质流失。糖皮质激素虽然能有效减轻炎症,但会增加骨折风险。因此,充足的钙和维生素D供应至关重要。对于许多类风湿性关节炎患者,建议进行骨密度测量。

相似文献

1
[Local and systemic bone effects of rheumatoid arthritis].类风湿关节炎的局部和全身骨骼影响
Z Rheumatol. 2012 Dec;71(10):869-73. doi: 10.1007/s00393-011-0927-y.
2
Alfacalcidol versus plain vitamin D in inflammation induced bone loss.阿法骨化醇与普通维生素D治疗炎症性骨质流失的比较
J Rheumatol Suppl. 2005 Sep;76:26-32.
3
Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.阿法骨化醇与普通维生素D治疗糖皮质激素/炎症诱导的骨质疏松症的比较
J Rheumatol Suppl. 2005 Sep;76:33-40.
4
Management of osteoporosis in rheumatoid arthritis patients.类风湿关节炎患者骨质疏松症的管理
Expert Opin Pharmacother. 2015 Mar;16(4):559-71. doi: 10.1517/14656566.2015.997709. Epub 2015 Jan 27.
5
Skeletal complications of rheumatoid arthritis.类风湿关节炎的骨骼并发症。
Osteoporos Int. 2017 Oct;28(10):2801-2812. doi: 10.1007/s00198-017-4170-5. Epub 2017 Aug 4.
6
[Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].[依据德国指南对骨质疏松症和类风湿性关节炎进行诊断与治疗。患者、初级保健医生和风湿病学家的调查结果]
Z Rheumatol. 2011 Sep;70(7):592-601. doi: 10.1007/s00393-011-0821-7.
7
[Calcium and vitamin D preparations in steroid osteoporosis in patients with rheumatoid arthritis].
Ter Arkh. 2007;79(5):89-92.
8
Strategies for the prevention and treatment of osteoporosis in patients with rheumatoid arthritis.类风湿关节炎患者骨质疏松症的预防和治疗策略。
Drugs Aging. 2006;23(10):773-9. doi: 10.2165/00002512-200623100-00001.
9
Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide.类风湿关节炎患者骨质疏松的药物治疗:文献复习与实用指南
Drugs Aging. 2019 Dec;36(12):1061-1072. doi: 10.1007/s40266-019-00714-4.
10
The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis.白细胞介素-6 在类风湿关节炎相关骨质疏松症中的作用。
Osteoporos Int. 2010 Aug;21(8):1287-93. doi: 10.1007/s00198-010-1192-7. Epub 2010 Mar 13.

引用本文的文献

1
[Osteoporosis-frequent comorbidity in patients with rheumatism].[骨质疏松症——风湿病患者的常见合并症]
Z Rheumatol. 2019 Apr;78(3):249-254. doi: 10.1007/s00393-019-0622-y.
2
[Multimorbidity in elderly rheumatic patients part 1].[老年风湿性疾病患者的多重疾病,第1部分]
Z Rheumatol. 2013 Aug;72(6):530-8. doi: 10.1007/s00393-012-1115-4.

本文引用的文献

1
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling.c-Src 和 IL-6 抑制成骨细胞分化并整合 IGFBP5 信号。
Nat Commun. 2012 Jan 17;3:630. doi: 10.1038/ncomms1651.
2
Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction.托珠单抗抑制类风湿关节炎的关节损伤进展,与其抗炎作用无关:炎症与破坏之间的联系被打破。
Ann Rheum Dis. 2012 May;71(5):687-93. doi: 10.1136/annrheumdis-2011-200395. Epub 2011 Nov 25.
3
Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels.
接受雷洛昔芬、阿仑膦酸钠或糖皮质激素治疗的绝经后类风湿关节炎女性患者血清中低羧化骨钙素水平较低。
J Endocrinol Invest. 2012 Jul;35(7):661-4. doi: 10.3275/7971. Epub 2011 Sep 30.
4
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes.在接受阿巴西普治疗的甲氨蝶呤初治、具有不良预后因素的类风湿关节炎患者中,持续缓解疾病和抑制影像学进展:2 年的结果。
Ann Rheum Dis. 2011 Nov;70(11):1949-56. doi: 10.1136/ard.2010.145268. Epub 2011 Aug 6.
5
Vitamin D receptor regulates TNF-mediated arthritis.维生素 D 受体调节 TNF 介导的关节炎。
Ann Rheum Dis. 2011 Jun;70(6):1122-9. doi: 10.1136/ard.2010.142331. Epub 2011 Mar 17.
6
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year.托珠单抗可抑制对甲氨蝶呤反应不足的类风湿关节炎患者的关节结构损伤:托珠单抗安全性及预防一年期关节结构损伤的随机安慰剂对照试验双盲治疗阶段结果
Arthritis Rheum. 2011 Mar;63(3):609-21. doi: 10.1002/art.30158.
7
Osteoblast physiology in normal and pathological conditions.成骨细胞生理学在正常和病理条件下。
Cell Tissue Res. 2011 Feb;343(2):289-302. doi: 10.1007/s00441-010-1086-1. Epub 2010 Dec 1.
8
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability.类风湿关节炎患者维生素 D 缺乏:患病率、决定因素以及与疾病活动度和残疾的相关性。
Arthritis Res Ther. 2010;12(6):R216. doi: 10.1186/ar3195. Epub 2010 Nov 29.
9
Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells.选择性糖皮质激素受体激动剂化合物 A 对人骨髓基质细胞成骨和免疫作用的分离。
Endocrinology. 2011 Jan;152(1):103-12. doi: 10.1210/en.2010-0456. Epub 2010 Nov 17.
10
Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.生物疗法治疗类风湿关节炎和强直性脊柱炎的全身骨骼效应。
Osteoporos Int. 2011 Apr;22(4):1023-36. doi: 10.1007/s00198-010-1462-4. Epub 2010 Oct 20.